Urological stent therapy system and method

• US 5,830,179 A
• Filed: 04/09/1996
• Issued: 11/03/1998
• Est. Priority Date: 04/09/1996
• Status: Expired due to Fees

• Current Assignee: Endocare Inc. (Siemens AG)
• Original Assignee: Endocare Inc. (Siemens AG)
• Inventors: Mikus, Paul, Moseley, William
• Primary Examiner(s): YASKO JR, JOHN D
• Application Number:
  US08/629,650
• Time in Patent Office: 938 Days
• Field of Search: 604/49, 604/52, 604/104-109, 604/281, 606/108, 606/191, 606/192, 606/194, 606/198, 623/1, 623/12
• US Class Current: 604/517
• CPC Class Codes: A61F 2/04 Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts A61F2/18, A61F2/20 take precedence; devices, other than stent-grafts, providing patency to, or preventing collapsing of, tubular structures of the body other than stent-grafts, e.g. stents A61F2/82; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95
• CPC Class Codes: A61F 2/88 the wire-like elements formed as helical or spiral coils forming a net-like or mesh-like structure A61F2/90
• CPC Class Codes: A61F 2002/048 Ureters
• CPC Class Codes: A61F 2250/0039 differing in diameter
• CPC Class Codes: A61L 2400/16 Materials with shape-memory or superelastic properties
• CPC Class Codes: A61L 31/022 Metals or alloys

Abstract

A stent system and method for use in the prostate gland. The stent is made of a shape memory alloy such as nitinol, and has a low temperature martensite state, with a martensite transition temperature below body temperature, and a high temperature austenite state, with an austenite transition temperature at or above body temperature, and a memorized shape in the high temperature austenite state which is a helical coil of diameter large enough to hold the prostatic urethra open. The stent is used to heat the prostate and is left in the prostatic urethra while the prostate heals. After the prostate is substantially healed, the stent is cooled to its martensite state and is easily removed from the urethra.

Claims

1. A method of treating a prostate gland by inserting a stent within the prostatic urethra of a patient, said method comprising:

providing a metallic stent sized and dimensioned to fit within the prostatic urethra of a patient;

providing a stent delivery catheter suitable for insertion into the prostatic urethra;

mounting the stent on the stent delivery catheter, inserting the stent delivery catheter with the stent mounted thereon into the prostatic urethra, and placing the stent within the urethra;

heating the stent by applying RF energy to the stent, including heating the stent to a temperature high enough to cause thermal damage to the prostate gland;

ceasing the heating of the stent when a portion of the prostate gland has been thermally damaged;

allowing the prostate gland to heal after it is thermally damaged, and leaving the stent in the prostatic urethra while the prostate gland is healing;

removing the stent from the prostatic urethra when the prostate gland has substantially healed from the thermal damage.

2. A method of treating a prostate gland by inserting a stent within the prostatic urethra of a patient, said method comprising:

providing a metallic stent sized and dimensioned to fit within the prostatic urethra of a patient, said stent comprised of shape memory metal with a low temperature state in which the stent is easily deformable and a high temperature state in which the stent exhibits shape memory and reverts to a memorized shape of a helical coil stent, said high temperature state occurring when the stent is heated above the shape memory transition temperature characteristic of the metal, and said low temperature state occurring when the stent is cooled to below a low temperature transition temperature characteristic of the metal;

providing a stent delivery catheter suitable for insertion into the prostatic urethra;

mounting the stent on the stent delivery catheter, inserting the stent into the prostatic urethra while it is in its easily deformable low temperature state;

placing the stent within the urethra by heating the stent to its shape memory transition temperature and allowing the stent to revert to its memorized shape of a helical coil stent;

heating the stent by applying RF energy to the stent, including heating the stent to a temperature high enough to cause thermal damage to the prostate gland;

ceasing the heating to the stent when a portion of the prostate gland has been thermally damaged;

allowing the prostate gland to heal after it is thermally damaged, and leaving the stent in the prostatic urethra while the prostate gland is healing;

cooling the stent to its easily deformable low temperature state and removing the stent from the prostatic urethra.